Are you launching your products strategically?

Key Takeaways

  • Being the first mover in a specific treatment area/ target population or having a new mechanism of action (MoA) provides a significant advantage to boost product sales; this worked for approx. 35% of the molecules
  • A significant improvement in efficacy and being in a segment with high unmet needs still yields results; approx. 50% of the molecules belong to this category.
  • Finally, if you are planning to launch a product with an MoA similar to that of other already approved molecules-
    — Choose an indication yet to gain approval from among formal molecules (Tecentriq)
    — Focus on providing benefits to customers such as pricing advantage
    or flexibility to physicians/patients (Kisqali)



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Acuity Knowledge Partners

Acuity Knowledge Partners

We write about financial industry trends, the impact of regulatory changes and opinions on industry inflection points.